Award recordCONTRACT

ATLANTIC BIOLOGICALS CORP.

PIID 36C26121P1435· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2021· $15,079 net obligations· UEI DQAQYBV4FLQ3· FL

Description

DE-OBLIGATE FUNDS

Base award description: CHLORHEXIDINE GABAPENTIN LOPERAMIDE

First action · last action
2021-08-10 · 2022-05-27
Transactions
2
First transaction's obligation
$26,529
Base + all options value (sum of deltas)
$15,079
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$26,529$0Base award · 2021-08-10 · this action $26,529 · running total $26,529Modification P00002 · 2022-05-27 · this action -$11,450 · running total $15,079
  • Base2021-08-10+$26,529= $26,529
  • Mod P000022022-05-27-$11,450= $15,079
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-08-10+$26,529$26,529CHLORHEXIDINE GABAPENTIN LOPERAMIDE
Mod P00002· FUNDING ONLY ACTION2022-05-27−$11,450$15,079DE-OBLIGATE FUNDS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI DQAQYBV4FLQ3)

AwardOffice · PSC / listingNet obligationsFY
36C77022P0286NATIONAL CMOP OFFICE (36C770) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$95,079FY2022
36C77021P0552NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$0FY2021
36C77021P0419NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$13,101FY2021
36C77021P0394NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$49,905FY2021
36C77021P0158NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$63,788FY2021
36C77021P0122NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$322,840FY2021

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26121P1435_3600_-NONE-_-NONE- · retrieved 2026-09-26.